MetaVia Inc. - Common Stock (MTVA)

MetaVia Inc. (NASDAQ: MTVA) shares drop over 10% on Thursday due to profit-taking despite announcing peer-reviewed data supporting its anti-fibrotic MASH drug candidate.

NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Investor Forum, held March 11th – 12th, are now available for on-demand viewing.

Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com

Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.

Wondering what's happening in Monday's pre-market session? Find an overview in this article.

As the “Magnificent 7” continue to dominate headlines, a new group of micro-cap contenders—dubbed the “Mag 7 Undercard”—is catching the attention of high-risk, high-reward traders. Trading under $1, these stocks represent speculative opportunities across entertainment, technology, mining, shipping, biotech, and carbon markets.

The US market session of Monday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.